Skip to content

Cognitive Behavioral Therapy for Insomnia in Euthymic Bipolar Disorder

Cognitive Behavioral Therapy for Insomnia in Euthymic Bipolar Disorder: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01704352
Enrollment
38
Registered
2012-10-11
Start date
2013-01-31
Completion date
2018-08-31
Last updated
2018-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder, Insomnia

Keywords

Cognitive Behavioral Therapy, CBT-I

Brief summary

Patients with bipolar disorder suffer from sleep disturbances, even in euthymic phases. Changes in sleep are frequent signs of a new episode of (hypo)mania or depression. Cognitive behavioral therapy for insomnia is an effective treatment for primary insomnia, but has not been introduced to patients with bipolar disorder. The aim is to compare cognitive behavioral therapy added to 'treatment as usual' with just 'treatment as usual'. The investigators hypothesize that cognitive behavioral therapy will improve quality of sleep, stabilize minor mood variations and prevent new mood episodes in euthymic patients with bipolar disorder and insomnia.

Interventions

BEHAVIORALCognitive behavioral therapy for insomnia

CBT-I will be given during 3-6 sessions according to need by two therapists being either psychiatrists or psychologists with clinical experience in CBT-I.

Sponsors

St. Olavs Hospital
CollaboratorOTHER
Norwegian University of Science and Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Fulfilling criteria for SCID-1-verified bipolar I or II disorder * Euthymic, as defined by Montgomery Åsberg Depression Rating Scale (MADRS) not higher than eleven, and Young Mania Rating scale (YMRS) not higher than five. * Fulfilling DSM-IV criteria for primary insomnia or insomnia related to another mental disorder, as assessed by the Insomnia Interview Schedule (IIS).

Exclusion criteria

* Being or having been in a defined affective episode the last month before inclusion * Hospitalization in the last two months before inclusion * Working night shifts * Sleep apnea * Medical conditions incompatible with participation. * Inability to cooperate in the 3-week initial phase before randomization.

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in quality of sleep at 8 weeksAt 8 weeks from randomizationAs assessed by the Insomnia Severity Index (ISI)
Change from baseline in quality of sleep at 6 months follow-up6 months from end of treatment phaseAs assessed by the Insomnia Severity Index (ISI)

Secondary

MeasureTime frameDescription
Variation in sleep registration from baseline to 8 weeksAt 8 weeksComparing registrations of sleep by sleep diaries, actigraphs and polysomnography.
Variation in sleep registration from baseline to 6 months follow-upAt 6 monthsComparing registrations of sleep by sleep diaries, actigraphs and polysomnography.

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026